Nestle logo

Nestle

Last updated January 31, 2026
125
Innovation Areas
3,230
Inventors
16
Collaborations

Linalool meroterpenoid molecular scaffolds: NestleRecent Research Landscape

Dysphagia and metabolic inefficiency increase healthcare costs and patient risk. This formulation leverages the synergistic interaction between cinnamaldehyde and zinc to modulate sensory and metabolic pathways.

What technical problems is Nestle addressing in Linalool meroterpenoid molecular scaffolds?

Impaired swallowing reflex

(3)evidences

Dysphagia and low metabolic rates represent physiological limitations in nutrient processing and energy balance. Addressing these improves patient safety and weight management outcomes.